3P innovation

Activities: Manufacturing Research & Development Digital Pharmaceutical

3P Innovation is a UK-based engineering and custom automation company

Visit website

Profile

3P Innovation works collaboratively with pharma and medical device businesses to help develop new products, devices and production processes. 3P specialises in aseptic automation and powder/liquid filling technologies. The company designs and builds scalable production solutions - supporting from lab-scale / bench top equipment to pilot plant and full production systems.

They are active in the cell and gene sector, parenterals, reconstitution devices, inhalers and sustained release drug products.

Trending Articles

  1. Olon strengthens market position with acquisitions ahead of CPHI Milan Two new acquisitions expand Olon’s service offerings and production capacity
  2. Improving the sustainability of pharmaceutical freeze drying with ECO Mode Freeze dryers are typically associated with high levels of energy consumption; to counteract this issue, GEA Pharma & Healthcare has introduced the LYOVAC ECO Mode, which...
  3. Microbial identification of drug contamination: MALDI-TOF MS as an efficient alternative This article describes the growing need for fast and accurate microbial detection in the pharmaceutical manufacturing supply chain
  4. Almac Group announces £11m investment to expand global analytical services The Almac Group has announced an £11m investment and the creation of more than 100 new jobs to expand its global analytical services capabilities
  5. Neopac unveils new Polyfoil mono-material barrier mini tubes Small-size tubes enhance protection and versatility for pharmaceutical and oral care applications

Upcoming event

ISCC

15-18 October 2024 | Conference | Milan, Italy See all

Related Content

Manufacturing

Ensuring cGMP compliance in cell and gene therapy manufacturing

3P discusses how companies can scale up their CGT manufacturing protocols while remaining compliant with stringent global regulations
Manufacturing

Cellular Origins and 3P innovation collaborate to automate the CGT manufacturing process

The companies will integrate their technologies to automate the sterile filling of vials and other open format containers in commercial CGT manufacturing
Manufacturing

3P innovation secures multimillion-pound deal with Dalton Pharma Services for advanced robotic powder filling technology

Pharmaceutical manufacturing company, Dalton Pharma Services (DPS, a Seikagaku Group company), has recently commissioned 3P innovation (Warwick, UK) to design and construct a fully automated state-of-the-art high-speed aseptic powder filling line to expedite the delivery of drugs to market in a more compliant, efficient and economical manner
Manufacturing

Clusters, megadeals, "Cellicon Valley" and the "Golden Triangle"

Dr David Seaward, 3P founder and Projects Director explains that whenever new technologies emerge, there are typically clusters of innovator companies

What are ATMPs and why do they matter?

3P Innovation looks at advanced therapy medicinal products (ATMPs), as they are known in Europe, or cellular and gene therapy (C&GT) products in the US

Cell and gene therapy: converting a Rolls-Royce into a Ford?

Many believe, writes Dr David Seaward, 3P Founder and Engineering Director, that what semiconductors and computers were to the latter half of the 20th century, biotechnology will be to the 21st
Subscribe now